As the most commonly diagnosed malignancy and the 2nd leading cause of cancer-related death in men, prostate cancer (PC) is a major health care problem in the Nordic countries, where incidences will rise by 40% in the next 20-ys due to population aging.
The PERAID project proposes to implement personalized medicine (PM) in severe infectious diseases, specifically focusing on the life-threatening necrotizing soft tissue infections (NSTI) as well as the large heterogeneous group of sepsis patients.
Sleep apnea is a prevalent nocturnal breathing disorder and causes a high burden to the affected individuals, as well as to society and economy. However, current diagnostic methods for sleep apnea are complicated and labour-intensive processes involving various shortcomings related to measuring, analysing and reporting of data.
The NORDTREAT project will build on the achievements within recent large-scale European initiatives that includes cross-disciplinary collaborations between academia, hospitals, biomedical companies and patient organisations. The overall aim is to improve Inflammatory bowel disease (IBD) patients' prognosis and quality of life by introducing a novel personalized medicine algorithm that is based on recently generated -omics data.
NordForsk is issuing a call for proposals on Japan–Nordic collaborations on health data research. The call has a total budget of approximately NOK 25 million, and the deadline for the call for proposals is 7 October 2021.
De nordiske landene har til sammen satt av over tre milliarder norske kroner til forskning om COVID-19. Størstedelen av midlene er satt av til medisinsk forskning, med Sverige som den klart største bidragsyteren
This report maps initiatives by research funding organisations in the Nordic countries, government agencies as well as private foundations, to further research related to COVID-19.
